French Research Institutes
INCa – Institut National du Cancer (The National Cancer Institute) The National Cancer Institute (INCa) is the state agency of health and scientific expertise in oncology in…
One of the special features of INNOTHERA, lies in its dual competency: pharmaceutical products and medical textiles. These two areas of expertise complement each other in a harmonious way and work towards the same end, that of treating common daily pathologies, such as venous disease. INNOTHERA’s pharmaceutical laboratory activity enables the Group to apply scientific knowledge and strict pharmaceutical processes to the medical textiles sector, thereby giving it a major advantage over its competitors.
Thanks to its human touch, INNOTHERA can concentrate its efforts on meeting assignments promptly and on achieving an excellent response rate, which is absolutely needed for managing the diversity of profiles and cultures within the group.
Currently, the INNOTHERA Group’s production is 100 % French, with exports amounting to more than 65 % of total sales, and covering more than 100 countries.
This is the price of a disciplined organisation and industrial process perfectly mastered that Innothera products in its French factories more than 20 drugs, controls 15 different dosage forms and distributes medicines in more than 100 countries.
Contact
Web: innothera.fr/en/
INCa – Institut National du Cancer (The National Cancer Institute) The National Cancer Institute (INCa) is the state agency of health and scientific expertise in oncology in…
DSS Direction de la Sécurité (Department of Social Security) Key People: Director General Mathilde Lignot-Leloup The Directorate of Social Security (DSS) supervises all social security organizations: general scheme funds,…
Commission des Affaires Sociales de l’Assemblée Nationale (Commission of Social Affairs, National Assembly) Key People: Brigitte Bourguignon, Chairwoman Olivier Véran, General Reporter The Social Affairs Committee of the National Assembly is…
Joël Jaouen, president of France Alzheimer, provides important insights into the role and objectives of the patient association. He explains why France Alzheimer together with other learned societies filed a…
PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in French pharma’s industry, regulatory affairs, reimbursement and pricing. Maurice-Pierre Planel — President of CEPS Maurice-Pierre Planel Has been…
Lundbeck France and Benelux’s Lourdes Pla discusses Europe-wide restructuring, the importance of the French affiliate to the global group and the government’s attitude towards healthcare and neuroscience. We are…
Gérard Raymond, president of the Fédération Francaise des Diabétiques (FFD – French Diabetes Federation), gives an update on the situation of diabetes in France and explains the challenges for patient…
Christophe Cizeron, president of Lyonbiopole, discusses the important economic and industrial position of the research cluster in the Rhone-Alps Region as well as the challenges posed by domestic and international…
Vincent Leonhardt explains how the French administration’s zeal for life science innovation can actually place pressure on some pharma SMEs. He also discusses the challenges he faced during his first…
Pierre Moustial, CEO of URGO Group, explains the life-changing advancement in wound care treatments that URGO has been providing to patients all over the world as well as his upcoming…
Thomas Courbe, general director of the DGE (Direction Générale des Entreprises – General Directorate for Enterprises), speaks about the role of the DGE and the implementation of new policies oriented…
Stéphane Roques, CEO of Medicen, the health care cluster for the Paris region, discusses his vision for Medicen and the changes he has made during his first few months in…
See our Cookie Privacy Policy Here
